Nebacumab

DB13535ExperimentalProtein Based Therapies

Nebacumab: Overview.

Resolves to

Compound
UNII908FWN27WKCAS138661-01-5
Clinical / RWD
ATCJ06BC01

What you can answer from here — as of February 21, 2021

381Drug interactionsStructured to mechanism, not free text
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in

Which companies are running trials of Nebacumab, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In